Publications (First author/Corresponding author)
2024
75. 吴伟, 覃弦, 瞿凯, 张坤, 朱力, 钟元, 红细胞膜自发定向包被ROS响应的纳米前药及其应用[P]. 发明专利, ZL202211361359.2.
74. Duan X, Yang X, Mou N, Cao Y, He Z, Zhu L, Zhong Y, Zhang K, Qu K, Qin X, Chen Q,* Luo Y,* Wu W,* Reactive oxygen species-triggered carbon dots-based biomimetic nanotheranostic agents for atherosclerosis management. Advanced Functional Materials, 2024, Accepted. （IF：18.5, Nature Index）
73. Ni S, Zhang K, Zhao X, Wu S, Yan M, Sun D,* Zhu L,* Wu W,* Phenylboronic acid functionalized dextran loading curcumin as nano-therapeutics for promoting the bacteria-infected diabetic wound healing. International Journal of Biological Macromolecules, 2024, 273(1): 133062. （IF：7.7）
72. Zhu L, Zhong Y, Yan M, Ni S, Zhao X, Wu S, Wang G, Zhang K, Chi Q, Qin X, Li C,* Huang X,* Wu W,* Macrophage membrane-encapsulated dopamine-modified poly-cyclodextrin multifunctional biomimetic nanoparticles for atherosclerosis therapy. ACS Applied Materials & Interfaces, 2024, 16, 25, 32027-32044 （IF：8.3）
71. Qin X,† Zhu L,† An X, Zhang C, Li J, Yan F, Zhang W, Qu K,* Zhang K,* Wu W,* Wu G,* Hybrid Cell Membranes Camouflaged Copper-Loaded Nano-Prodrug for Tumor Angiogenesis Inhibition and Cell Cuproptosis. Chemical Engineering Journal, 2024, 493: 152323. （IF：13.3）
70. He Z, Chen Q, Duan X, Zhong Y, Zhu L, Mou N, Yang X, Cao Y, Han Z, He H, Wu S, Wang G, Qin X, Qu K, Zhang K,* Liu J,* Wu W,* Reactive Oxygen Species-Responsive Nano-platform with Dual-Targeting and Fluorescent Lipid-Specific Imaging Capabilities for the management of Atherosclerotic Plaques. Acta Biomaterialia, 2024, 181: 375-390. （IF：9.4）
69. Qu K,† Zhong Y,† Zhu L,† Mou N, Cao Y, Liu J, Wu S, Yan M, Yan F, Li J, Zhang C, Wu G, Kun Zhang,* Qin X,* Wu W,* A Macrophage Membrane-Functionalized, Reactive Oxygen Species-Activatable Nanoprodrug to Alleviate Inflammation and Improve the Lipid Metabolism for Atherosclerosis Management. Advanced Healthcare Materials, 2024, Accepted. （IF：10）
68. Ma Y,† Yi J,† Ruan J,† Ma J, Yang Q, Zhang K, Zhang M, Zeng G, Jin L, Huang X, Li J,* Yang H,* Wu W,* Sun D,* Engineered Cell Membrane-Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation. Advanced Healthcare Materials, 2024, Accepted. （IF：10）
67. Chen J,† Luo A,† Xu M, Zhao Y, Xu Z, Yu S, Zhu L,* Wu W,* Yang D,* The application of phenylboronic acid pinacol ester functionalized ROS-responsive multifunctional nanoparticles in the treatment of Periodontitis. Journal of Nanobiotechnology, 2024, 22: 181.（IF：10.6）
66. 吴伟, 张坤, 瞿凯, 覃弦, 朱力, 钟元, 前药封装的工程化益生菌及其制备方法与应用[P]. 发明专利, ZL202211403974.5.
65. Qin X,† Zhu L,† Zhong Y, Wang Y, Luo X, Li J. Yan F, Wu G, Qiu J, Wang G, Qu K,* Zhang K,* Wu W,* Universal cell membrane camouflaged nano-prodrugs with right-side-out orientation adapting for positive pathological vascular remodeling in atherosclerosis. Chemical Science, 2024, 15: 7524-7544. （IF：7.6, Nature Index）
64. Qu L,† Li Y,† Liu F,† Fang Y, He J, Ma J, Xu T, Wang L, Lei P, Dong H, Jin L, Yang Q,* Wu W,* Sun D,* Microbiota-Gut-Brain Axis Dysregulation in Alzheimer's Disease: Multi-Pathway Effects and Therapeutic Potential. Aging and Disease, 2024, 15 (3): 1108-1131. （IF：7）
63. Wu S,† Zhu L,† Ni S, Zhong Y, Qu K, Qin X, Zhang K, Wang G, Sun D,* Deng W,* Wu W,* Hyaluronic acid-decorated curcumin-based coordination nanomedicine for enhancing the infected diabetic wound healing. International Journal of Biological Macromolecules, 2024, 263(1): 130249. （IF：7.7）
62. Huang X,* Mu N, Ding Y, Huang R, Wu W,* Li L,* Chen T,* Tumor microenvironment targeting for glioblastoma multiforme treatment via hybrid cell membrane coating supramolecular micelles. Journal of Controlled Release, 2024, 366: 194-203. （IF：10.5）
61. Li H, Zhu L, Zhang Y, Yang L, Wu W,* Yang D,* Biomimetic Nanotherapeutics for Homotypic-Targeting Photothermal/Chemotherapy of Oral Cancer. Journal of Controlled Release, 2024, 366: 28-43. （IF：10.5）
60. Ma J, Fang Y, Yu H, Yi J, Ma Y, Lei P, Yang Q, Jin L, Wu W,* Li H,* Sun D,* Recent advances in living algae seeding wound dressing: focusing on diabetic chronic wound healing. Advanced Functional Materials, 2024, 34(2): 2308387. （IF：18.5, Nature Index）
59. Chen Q, Duan X, Yu Y, Ni R, Song G, Yang X, Zhu L, Zhong Y, Zhang K,* Qu K,* Yang D,* Qin X,* Wu W,* Target functionalized carbon dot nanozymes with dual-model photoacoustic and fluorescence imaging for visual therapy in atherosclerosis. Advanced Science, 2024, 11(6): 2307441. （IF：14.3）
58. Yan M,† Liang W,† Du L, Guo R, Cao Y, Ni S, Zhong Y, Zhang K, Qu K, Qin X, Chen L,* Wu W,* Metronidazole-loaded polydopamine nanomedicine with antioxidant and antibacterial bioactivity for periodontitis. Nanomedicine, 2024, 18(29): 2143-2157. （IF：4.7）
2023
57. Zhong Y,† Maruf A,† Qu K, Milewska M, Wandzik I*, Mou N, Cao Y, Wu W,* Nanogels with covalently bound and releasable trehalose for autophagy stimulation in atherosclerosis. Journal of Nanobiotechnology, 2023, 21: 472.（IF：10.6）
56. 吴伟, 刘博妍, 钟元, 焉梦, 吴帅, 朱力, 抑制损伤血管内膜增生的纳米药物及其应用[P]. 发明专利, ZL202111171093.0.
55. Liu J, He Z, Zhong Y, Zhu L, Yan M, Mou N, Qu K, Qin X, Wang G, Zhang K,* Yang W,* Wu W,* Reactive Oxygen Species-Responsive Sequentially Targeted AIE Fluorescent Probe for Precisely Identifying the Atherosclerotic Plaques. ACS Applied Materials & Interfaces, 2023, 15 (40): 47381-47393. （IF：8.3）
54. Zhu L, Li H, Li J, Zhong Y, Wu S, Yan M, Ni S, Zhang K, Wang G, Qu K,* Yang D,* Qin X,* Wu W,* Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis. Journal of Nanobiotechnology, 2023, 21: 307. （IF：10.2）
53. Lei P, Yu H, Ma J, Du J, Fang Y, Yang Q, Zhang K, Luo L, Jin L,* Wu W,* Sun D,* Cell membrane nanomaterials composed of phospholipids and glycoproteins for drug delivery in inflammatory bowel disease: A review. International Journal of Biological Macromolecules, 2023, 249: 126000. （IF：7.7）
52. Ye J; Liang W; Wu L; Guo R; Wu W,* Yang D,* Chen L,* Antimicrobial effect of Streptococcus salivarius outer membrane-coated nanocomplexes against Candida albicans and oral candidiasis. Materials & Design, 2023, 233: 112177. （IF：7.6）
51. Chen H, Lei P, Ji H, Ma J, Fang Y, Yu H, Du J, Qu L, Yang Q, Wu W,* Jin L,* Sun D,* Escherichia coli Nissle 1917 ghosts alleviate inflammatory bowel disease in zebrafish. Life Sciences, 2023, 329: 121956. （IF：5.2）
50. Wang L, Liu F, Fang Y, Ma J, Wang J, Qu L, Yang Q, Wu W,* Jin L,* Sun D,* Advances in Zebrafish as a Comprehensive Model of Mental Disorders. Depression and Anxiety, 2023, 2023: 6663141. （IF：4.7）
49. Qu L,† Liu F,† Fang Y,† Wang L, Chen H, Yang Q, Dong H, Jin L,* Wu W,* Sun D,* Improvement in Zebrafish with Diabetes and Alzheimer's Disease Treated with Pasteurized Akkermansia muciniphila. Microbiology Spectrum, 2023, 11(3): . （IF：3.7）
48. Sun P, Jiao J, Wang X, Chen L, Chen Z, Zhang K, Qu K, Qin X, Yang Z,* Zhong J,* Wu W,* Nanomedicine hybrid and catechol functionalized chitosan as pH-responsive multi-function hydrogel to efficiently promote infection wound healing. International Journal of Biological Macromolecules, 2023, 238: 124106. （IF：7.7）
47. Lin B,† Ma J,† Fang Y,† Lei P, Wang L, Qu L, Wu W,* Jin L,* Sun D,* Advances in zebrafish for diabetes mellitus with wound model. Bioengineering, 2023, 10(3): 330. （IF：3.8）
46. Chen H,† Lei P,† Ji H,† Yang Q, Peng B, Ma J, Fang Y, Qu L, Li H, Wu W,* Jin L,* Sun D,* Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies. Materials Today Bio, 2023, 18: 100543. （IF：8.7, ESI）
45. Qin X,† Zhu L,† Zhong Y, Wang Y, Wu G, Qiu J, Wang G, Qu K,* Zhang K,* Wu W,* Spontaneously Right-Side-Out-Orientated Coupling-Driven ROS-Sensitive Nanoparticles on Cell Membrane Inner Leaflet for Efficient Renovation in Vascular Endothelial Injury. Advanced Science, 2023, 10(6): 220509. （IF：14.3）
44. Zhang K,† Zhu L,† Zhong Y, Xu L, Lang C, Chen J, Yan F, Li J, Qiu J, Chen Y, Sun D, Wang G, Qu K,* Qin X,* Wu W,* Prodrug Integrated Envelope on Probiotics to Enhance Target Therapy for Ulcerative Colitis. Advanced Science, 2023, 10(4): 2205422. （IF：14.3）
43. 曹钰, 牟年莲, 朱力, 王溢, 王贵学,* 吴伟,* 红细胞膜仿生纳米药物载体在动脉粥样硬化治疗中的应用研究进展. 中国动脉硬化杂志, 2023, 1: 1-8.
42. Li J,† Zhu L,† Wu S, Wang G, Chen Y*, Wu W,* MPEG-phenylboronic acid modified doxorubicin as the efficient pathological pH-responsive nanoplatform for potential anti-cancer delivery. Macromolecular Research, 2023, 31: 181-191. （IF：2.8）
2022
41. Yan M, Zhu L, Wu S, Cao Y, Mou N, Chi Q, Wang G, Yuan Zhong*, Wu W,* ROS responsive polydopamine nanoparticles to relieve oxidative stress and inflammation for ameliorating acute inflammatory bowel. Biomaterials Advances (Materials Science & Engineering C), 2022, 142: 213126. （IF：5.5）
40. Weng L,† Wu L,† Guo R,† Ye J, Liang W, Wu W,* Chen L,* Yang D,* Lactobacillus cell envelope-coated nanoparticles for antibiotic delivery against cariogenic biofilm and dental caries. Journal of Nanobiotechnology, 2022, 20: 356. （IF：10.6）
39. Obaid EAMS,† Wu S,† Zhong Y, Yan M, Zhu L, Li B, Wang Y*, Wu W,* Wang G,* pH-responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy. Biomaterials Science, 2022, 10: 4837-4847. （IF：5.8）
38. Wang L,† Ma J,† Wu W,† Fang Y, Liu F, Yang Q, Hu X, Gu X, He Z, Sun D,* Jin L,* Zhang X,* Effect of aerobic exercise as a treatment on type 2 diabetes mellitus with depression-like behavior zebrafish. Life Sciences, 2022, 300: 120578. （IF：5.2）
37. Zhong Y, Qu K, Yan W, Zhang K, Qin X, Wang Y, Yan M, Wu S, Zhu L, Obaid E, Wang G, Wu W,* Overexpressed VLA-4 on Endothelial Cell Membrane Camouflaging the Pathological Reactive Oxygen Species Responsive Prodrug to Enhance Target Therapy for Atherosclerosis. Chemical Engineering Journal, 2022, 442: 136198. （IF：13.3）
36. Zhu L, Zhong Y, Wu S, Yan M, Cao Y, Mou N, Wang G, Sun D,* Wu W,* Cell membrane camouflaged biomimetic nanoparticles: Focusing on tumor theranostics. Materials Today Bio, 2022, 14: 100228. （IF：8.7）
35. Andy W, Wang Y, Tang D, Zhong Y, Liu B, Yan M, Qiu J, Wu W,* Wang G,* Study of Lovastatin and L-Arginine Co-loaded PLGA Nanomedicine for Enhancing Nitric Oxide Production and eNOS Expression. Journal of Materials Chemistry B, 2022, 10: 607-624. （IF：6.1）
2021
34. Liu B, Yan W, Luo L, Wu S, Wang Y, Zhong Y, Tang D, Maruf A, Yan M, Zhang K, Qin X, Qu K, Wu W,* Wang G, Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia. Journal of Nanobiotechnology, 2021, 19: 374. （IF：10.6）
33. Ji H,† Peng R,†, Jin L, Ma J, Yang Q, Sun D,* Wu W.*. Recent advances in ROS-sensitive nano-formulations for atherosclerosis. Pharmaceutics, 2021, 13(9): 1452.（IF：4.9）
32. Zhong Y, Qin X, Wang Y, Qu K, Luo L, Zhang K, Liu B, Obaid E, Wu W,* Wang G,* “Plug and Play” Functionalized Erythrocyte Nanoplatform for Target Atherosclerosis Management. ACS Applied Materials & Interfaces, 2021, 13(29): 33862-33873. （IF：8.3）
31. Luo L, Zang G, Liu B, Qin X, Zhang Y, Chen Y, Zhang H, Wu W,* Wang G,* Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury. Theranostics, 2021, 11(16): 8043-8056.（IF：12.4, Back Cover）
30. Tang D,† Wang Y,† Wijaya A, Liu B, Maruf A, Wang J, Xu J, Liao X, Wu W,* Wang G,* ROS-responsive biomimetic nanoparticles for potential application in targeted anti-atherosclerosis. Regenerative Biomaterials, 2021, 8(4): rbab033. （IF：5.6）
29. Chen L, Chen W, Yu Y, Yang J, Jiang Q, Wu W,* Yang D,* Effect of chlorhexidine-loaded poly(amido amine) dendrimer on matrix metalloproteinase activities and remineralization in etched human dentin in vitro. Journal of the Mechanical Behavior of Biomedical Materials, 2021, 121: 104625. （IF：3.3）
28. Wang Y,† Zhang K,† Li T, Maruf A, Qin X, Luo L, Zhong Y, Qiu J, McGinty S, Pontrelli G, Liao X,* Wu W,* Wang G,* Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Theranostics, 2021, 11(1): 164-180.（IF：12.4, Front Cover, ESI）
2020
27. Peng R,† Ji H,† Jin L,† Lin S, Huang Y, Xu K, Yang Q, Sun D,* Wu W,* Macrophage-Based Therapies for Atherosclerosis Management. Journal of Immunology Research, 2020, 2020: 8131754. （IF：3.5）
26. Maruf A, Wang Y, Luo L, Zhong Y, Nurhidayah D, Liu B, Tang D, Rouf M A, Zhang H, Yin Y, Wu W,* Wang G,* Nanoerythrocyte Membrane–Enveloped ROS-Responsive 5-Aminolevulinic Acid Prodrug Nanostructures with Robust Atheroprotection. Particle & Particle Systems Characterization, 2020, 37: 2000021. （IF：2.7）
25. Wijaya A, Maruf A, Wu W,* Wang G,* Recent advances in micro- and nano-bubbles for atherosclerosis applications. Biomaterials Science, 2020, 8: 4920-4939. （IF：5.8）
2019
24. Sun D,†,* Chen J,† Wu W,† Tang J, Luo L, Zhang K, Jin L, Lin S, Gao Y, Yan X, Zhang C, MiR-802 causes nephropathy by suppressing NF-κB-repressing factor in obese mice and human. Journal of Cellular and Molecular Medicine, 2019, 23: 2863-2871. （IF：4.3）
23. Zhong Y, Wang Y, Luo L, Nurhidayah D, Maruf A, Gregersen H, Wu W,* Wang G,* Targeted polyethylenimine/(p53 plasmid) nanocomplexes for potential antitumor applications. Nanotechnology, 2019, 30: 145601. （IF：2.9）
22. Maruf A, Wang Y, Yin T, Huang J, Wang N, Durkan C, Tan Y, Wu W,* Wang G,* Atherosclerosis treatment with stimuli-responsive nanoagents: recent advances and future perspectives. Advanced Healthcare Materials, 2019, 8: 1900036. （IF：10）
21. Wang Y, Zhang K, Qin X, Li T, Qiu J, Yin T, Huang J, McGinty S, Pontrelli G, Ren J, Wang Q, Wu W,* Wang G,* Biomimetic nanotherapies: red blood cell based core–shell structured nanocomplexes for atherosclerosis management. Advanced Science, 2019, 6 (12): 1900172.（IF：14.3, ESI）
20. Sun D,† Chen J,† Wang Y, Ji H, Peng R, Jin L,* Wu W,* Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery. Theranostics, 2019, 9(23): 6885-6900. （IF：12.4）
19. Nurhidayah D, Maruf A, Zhang X, Liao X, Wu W,* Wang G,* Advanced Drug Delivery Systems: Mechanoresponsive Nano-Platforms Applicable in Atherosclerosis Management. Nanomedicine, 2019, 14(23): 3105-3122. （IF：4.7）
2018
18. Luo L,† Wu W,† Sun D,† Dai H, Wang Y, Zhong Y, Wang J, Maruf A, Nurhidayah D, Zhang X, Wang Y, Wang G,* Acid-Activated Melittin for Targeted and Safe Antitumor Therapy. Bioconjugate Chemistry, 2018, 29 (9): 2936-2944. （IF：4）
17. Wang Y, Zhong Y, Luo L, Li X, Yin T, Huang J, Zhang X, Wu W,* Wang G,* Synthesis and characterization of pyrene modified polyethylenimine as a novel fluorescent self-reporter for gene condensation. Materials Chemistry and Physics, 2018, 211: 177-180. （IF：4.3）
16. Wu W,†,* Luo L,† Wang Y,† Wu Q, Dai H, Li J, Durkan C, Wang N, Wang G,* Endogenous pH-Responsive Nanoparticles with programmable size changes for Targeted Tumor Therapy and Imaging Applications. Theranostics, 2018, 8: 3038-3058. （IF：12.4）
2017
15. Wu W, Lin Z, Liu Y, Xu X, Ding C, Li J,* Thermoresponsive hydrogels based on a phosphorylated star-shaped copolymer: mimicking the extracellular matrix for in situ bone repair. Journal of Materials Chemistry B, 2017, 5: 428-434. （IF：6.1）
14. Wu W,† Chen J,† Sun D,†,* Kong X, Xu D, Wang Y, Luo L, Zhang K, Xiao K,* Wang G,* Study on antibacterial performance and biocompatibility of a novel phosphorus-magnesium fiber. Materials Letters, 2017, 209: 562-565. （IF：2.7）
13. Chen J, Wu Q, Luo L, Wang Y, Zhong Y, Dai H, Sun D, Luo M-L, Wu W,* Wang G,* Dual tumor-targeted poly(lactic-co-glycolic acid)-polyethylene glycol–folic acid nanoparticles: a novel biodegradable nanocarrier for secure and efficient antitumor drug delivery. International Journal of Nanomedicine, 2017, 12: 5745-5760. （IF：6.6）
2016
12. Wu W,† Ye C,† Xiao H,† Sun X, Qu W, Li X, Chen M,* Li J,* Hierarchical mesoporous silica nanoparticles for tailorable drug release. International Journal of Pharmaceutics, 2016, 511: 104-109. （IF：5.3）
11. Chen T,† Wu W,† Xiao H,† Chen Y, Chen M, Li J,* Intelligent Drug Delivery System Based on Mesoporous Silica Nanoparticles Coated with an Ultra-pH-Sensitive Gatekeeper and Poly(ethylene glycol). ACS Macro Letters, 2016, 10: 55-58. （IF：5.1）
10. Li S,† Zhao Z,† Wu W,† Ding C, Li J,* Dual pH-responsive micelles with both charge-conversional property and hydrophobic-hydrophilic transition for effective cellular uptake and intracellular drug release. Polymer Chemistry, 2016, 7: 2202-2208. （IF：4.1）
9. Li R-Q,† Wu W,† Song H-Q, Ren Y, Yang M, Li J,* Xu F-J,* Well-defined reducible cationic nanogels based on functionalized low-molecular-weight PGMA for effective pDNA and siRNA delivery. Acta Biomaterialia, 2016, 41: 282-292. （IF：9.4）
8. Li X, Shang H, Wu W,* Li S, Lin Z, Duan J, Xu L, Li J,* Glucose-Responsive Micelles for Controlled Insulin Release Based on Transformation from Amphiphilic to Double Hydrophilic. Journal of Nanoscience and Nanotechnology, 2016, 16: 5457-5463.
2015
7. Wu W, Wang W, Li J,* Star polymers: Advances in biomedical applications. Progress in Polymer Science, 2015, 46:55-85.（IF：26, ESI）
2014
6. Wu W, Zhang Q, Wang J, Chen M, Li S, Lin Z, Li J,* Tumor-targeted aggregation of pH-sensitive nanocarriers for enhanced retention and rapid intracellular drug release. Polymer Chemistry, 2014, 5: 5668-5679. （IF：4.1）
5. Wu W, Wang J, Lin Z, Li X, Li J,* Tumor-acidity activated surface charge-conversion of polymeric nanocarriers for enhanced cell adhesion and targeted drug release. Macromolecular Rapid Communications, 2014, 35: 1679-1684. （IF：4.2）
4. Wu W, Wang W, Li S, Wang J, Zhang Q, Li X, Luo X, Li J,* Physiological pH-triggered morphological transition of amphiphilic block copolymer self-assembly. Journal of Polymer Research, 2014, 21: 494. （IF：2.6）
3. Wu W, Chen M, Wang J, Zhang Q, Li S, Li Z, Li J,* Nanocarriers with dual pH-sensitivity for enhanced tumor cell uptake and rapid intracellular drug release. RSC Advances, 2014, 4: 30780-30783. （IF：3.9）
2. Li S,† Wu W,† Xiu K, Xu F, Li Z,* Li J,* Doxorubicin loaded pH-responsive micelles capable of rapid intracellular drug release for potential tumor therapy. Journal of Biomedical Nanotechnology, 2014, 10: 1480-1489.
2011
1. Wu W, Liu J, Cao S, Tan H, Li J,* Xu F, Zhang X, Drug release behaviors of a pH sensitive semi-interpenetrating polymer network hydrogel composed of poly(vinyl alcohol) and star poly[2-(dimethylamino)ethyl methacrylate]. International Journal of Pharmaceutics, 2011, 416: 65-72. （IF：5.3）
主持科研项目：
1. 国家重点研发计划课题，2022/11-2025/10，260万；
2. 国家自然科学基金面上项目，2022/01-2025/12，58万；
3. 国家自然科学基金面上项目，2020/01-2023/12，57万；
4. 国家自然科学基金青年科学基金项目，2017/01-2019/12，20万；
5. 重庆市科卫联合重点项目，2024/01-2027/01，40万（联合资助）；
6. 重庆市自然科学基金面上项目，2021/07-2023/06，10万（联合资助）；
7. 重庆市基础科学与前沿技术研究专项一般项目，2017/07-2020/06, 5万；
8. 中央高校基本科研业务费学院科技型专项，2016/01-2017/12，7万；
9. 中央高校基本科研业务费学院科技型专项，2018/01-2019/12，4万；
10. 中国博士后基金特别资助项目，2017/07 -2018/05，15万 ；
11. 中国博士后基金面上项目，2017/01-2018/05，5万；
12. 重庆市博士后基金特别资助项目，2017/01-2017/11，10万；
13. 四川省科技创新苗子工程，2015/07 -2016/06，3万；
14. 重庆大学2018年度科研后备拔尖人才B类，2018/07-2021/07，40万；
15. 中央高校基本科研业务费“基础研究与前沿交叉学科方向培育项目”，2020/01-2021/12，15万；
